Antiemetic properties of the 5HT3-receptor antagonist, GR38032F.

Cancer Treat Rev

Glaxo Group Research Ltd., Ware, Herts, U.K.

Published: December 1987

GR38032F is a highly selective 5HT3-receptor antagonist which inhibits vomiting induced by cisplatin, cyclophosphamide or X-radiation in the ferret. Since cisplatin selectively increased the levels of 5HT and 5HIAA in the intestinal mucosa, a possible site of the antiemetic action of GR38032F may be on 5HT3-receptors on vagal afferents in the small intestine. The potent antiemetic action of GR38032F should be of clinical value in reducing the nausea and vomiting associated with radiotherapy or chemotherapy of cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0305-7372(87)90026-0DOI Listing

Publication Analysis

Top Keywords

5ht3-receptor antagonist
8
antiemetic action
8
action gr38032f
8
antiemetic properties
4
properties 5ht3-receptor
4
gr38032f
4
antagonist gr38032f
4
gr38032f gr38032f
4
gr38032f highly
4
highly selective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!